ruxolitinib 5 mg Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1/2 (1)

Interventional (1)

Chinese PLA General Hospital (1)

No (1)

No (1)

Adult (18+) (1)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadtumorigenicity

I am/have/hadcancer

I am/have/hadacute graft versus host disease

I am/have/hadacute graft-versus-host disease

I am/have/hadhematologic disorders

I am/have/hadhematologic malignancy

I am/have/hadgraft versus host disease

I am/have/hadallogeneic hematopoietic stem cell transplant

I am/have/hadblood disorder

I am/have/hadcell transplantation

added new label for I am/have/had

more

I am looking for

I am looking forregenerating islet derived protein 3

I am looking forruxolitinib

I am looking forcorticosteroids

I am looking forruxolitinib 5 mg

I am looking formethylprednisolone

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For pediatric ages
Recruiting in 10s
Interventional Study
all
Recruiting

Low Dose Ruxolitinib in Combination With Methylprednisolone

This study is to determine the efficacy and safety of combined Low dose Ruxolitinib With Methylprednisone as Initial Therapy for the aGVHD(acute graft-versus-host disease )

tumorigenicity

corticosteroids

regenerating islet derived protein 3

cancer

ruxolitinib 5 mg

0 views
19 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2026 All rights reserved.